The following articles are related to ‘News and Research’ at Psychology, Philosophy and Real Life.
The US Food and Drug Administration has issued new warnings about possible heightened risks of suicide in adults taking antidepressant medications. The warnings follow the FDA’s decision last year to require drug manufacturers to strengthen suicide warnings included on drug labels.
New research suggests that the anti-psychotic medication Seroquel (olanzapine) — can be an effective single-drug treatment for bipolar disorder.
Teenagers in the United States are being neglected, both medically and emotionally, according to the lead author of a new book assessing research on teen mental health problems. The book finds that while 20 percent of adolescents suffer from a mental health disorder, treatment does not feature as a priority on the US public health agenda.
New studies explore the connection between sleep and depression and suggest that treating insomnia may increase both the likelihood and the rate of recovery for individuals receiving treatment for major depression. Additional research examines the first melatoninergic antidepressant, agomelatine (Valdoxan), and its use as an adjunctive therapy for bipolar disorder.
New estimates suggest that bipolar disorder is over 4 times more common than previously believed, and that its cost in terms of lost productivity and higher suicide risk has been significantly underestimated, compared to the more familiar major depressive disorder. New research on lithium shows it is the single most effective psychopharmacological agent for reducing rates of suicide for those affected by bipolar disorder.
We comply with the HONcode standard for trustworthy health information: verify here.
